Global HER-2 Negative Breast Cancer Market Growth (Status and Outlook) 2026-2032

July 2026 | 84 pages | ID: G225028767ECEN
LP Information

Abstracts

The global HER-2 Negative Breast Cancer market size is predicted to grow from US$ 4953 million in 2025 to US$ 7675 million in 2032; it is expected to grow at a CAGR of 6.5% from 2026 to 2032.

The treatment of HER-2-negative breast cancer constitutes a comprehensive therapeutic regimen tailored to patients whose HER-2 status tests negative. Treatment strategies are determined based on hormone receptor status, disease stage, and recurrence risk, employing a combination of modalities including surgery, radiotherapy and chemotherapy, endocrine therapy, CDK4/6 inhibitors, immunotherapy, and PARP inhibitors.

The upstream segment of the market encompasses diagnostic testing, chemical drugs, endocrine agents, targeted therapies, immunotherapies, medical devices, and CRO/CDMO services; the downstream segment targets hospital oncology departments, specialized breast cancer clinics, and patients.

The global market for HER-2-negative breast cancer treatment is poised to evolve toward greater precision in molecular subtyping, long-term disease management, and combination therapies. For patients with HR-positive/HER-2-negative breast cancer, the core treatment strategy will remain endocrine therapy combined with CDK4/6 inhibitors; future developments are expected to further expand the use of targeted regimens involving PI3K, AKT, and mTOR inhibitors, as well as oral SERDs. Meanwhile, triple-negative breast cancer patients stand to benefit significantly from immune checkpoint inhibitors, PARP inhibitors, and novel antibody-drug conjugates (ADCs). As the utilization of genetic testing, companion diagnostics, and real-world data continues to rise, treatment decision-making will increasingly prioritize biomarkers, mechanisms of drug resistance, and individualized therapy, thereby driving improvements in treatment efficacy and extending patient survival.

LPI (LP Information)' newest research report, the ?HER-2 Negative Breast Cancer Industry Forecast? looks at past sales and reviews total world HER-2 Negative Breast Cancer sales in 2025, providing a comprehensive analysis by region and market sector of projected HER-2 Negative Breast Cancer sales for 2026 through 2032. With HER-2 Negative Breast Cancer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world HER-2 Negative Breast Cancer industry.

This Insight Report provides a comprehensive analysis of the global HER-2 Negative Breast Cancer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on HER-2 Negative Breast Cancer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global HER-2 Negative Breast Cancer market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for HER-2 Negative Breast Cancer and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global HER-2 Negative Breast Cancer.

This report presents a comprehensive overview, market shares, and growth opportunities of HER-2 Negative Breast Cancer market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Chemotherapy
• Radiation
• Hormonal Therapy
• Others

Segmentation by Route of Administration:

• Oral Therapy
• Intravenous Therapy
• Subcutaneous Therapy
• Local Therapy

Segmentation by Disease Stage:

• Early-Stage HER2-Negative Breast Cancer Treatment
• Locally Advanced HER2-Negative Breast Cancer Treatment
• Metastatic HER2-Negative Breast Cancer Treatment
• Recurrent HER2-Negative Breast Cancer Treatment
• Unresectable HER2-Negative Breast Cancer Treatment

Segmentation by Application:

• Hospital
• Clinic
• Other

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Eli Lilly and Company
• AstraZeneca
• GlaxoSmithKline(GSK)
• Novartis
• Pfizer
• Henlius
• Puma Biotechnology

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global HER-2 Negative Breast Cancer Market Size (2021-2032)
  2.1.2 HER-2 Negative Breast Cancer Market Size CAGR by Region (2021 VS 2025 VS 2032)
  2.1.3 World Current & Future Analysis for HER-2 Negative Breast Cancer by Country/Region (2021, 2025 & 2032)
2.2 HER-2 Negative Breast Cancer Segment by Type
  2.2.1 Chemotherapy
  2.2.2 Radiation
  2.2.3 Hormonal Therapy
  2.2.4 Others
  2.2.5 HER-2 Negative Breast Cancer Market Size by Type
    2.2.5.1 HER-2 Negative Breast Cancer Market Size CAGR by Type (2021 VS 2025 VS 2032)
    2.2.5.2 Global HER-2 Negative Breast Cancer Market Size Market Share by Type (2021-2026)
2.3 HER-2 Negative Breast Cancer Segment by Application
  2.3.1 Hospital
  2.3.2 Clinic
  2.3.3 Other
  2.3.4 HER-2 Negative Breast Cancer Market Size by Application
    2.3.4.1 HER-2 Negative Breast Cancer Market Size CAGR by Application (2021 VS 2025 VS 2032)
    2.3.4.2 Global HER-2 Negative Breast Cancer Market Size Market Share by Application (2021-2026)

3 HER-2 NEGATIVE BREAST CANCER MARKET SIZE BY PLAYER

3.1 HER-2 Negative Breast Cancer Market Size Market Share by Player
  3.1.1 Global HER-2 Negative Breast Cancer Revenue by Player (2021-2026)
  3.1.2 Global HER-2 Negative Breast Cancer Revenue Market Share by Player (2021-2026)
3.2 Global HER-2 Negative Breast Cancer Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 HER-2 NEGATIVE BREAST CANCER BY REGION

4.1 HER-2 Negative Breast Cancer Market Size by Region (2021-2026)
4.2 Global HER-2 Negative Breast Cancer Annual Revenue by Country/Region (2021-2026)
4.3 Americas HER-2 Negative Breast Cancer Market Size Growth (2021-2026)
4.4 APAC HER-2 Negative Breast Cancer Market Size Growth (2021-2026)
4.5 Europe HER-2 Negative Breast Cancer Market Size Growth (2021-2026)
4.6 Middle East & Africa HER-2 Negative Breast Cancer Market Size Growth (2021-2026)

5 AMERICAS

5.1 Americas HER-2 Negative Breast Cancer Market Size by Country (2021-2026)
5.2 Americas HER-2 Negative Breast Cancer Market Size by Type (2021-2026)
5.3 Americas HER-2 Negative Breast Cancer Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC HER-2 Negative Breast Cancer Market Size by Region (2021-2026)
6.2 APAC HER-2 Negative Breast Cancer Market Size by Type (2021-2026)
6.3 APAC HER-2 Negative Breast Cancer Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe HER-2 Negative Breast Cancer Market Size by Country (2021-2026)
7.2 Europe HER-2 Negative Breast Cancer Market Size by Type (2021-2026)
7.3 Europe HER-2 Negative Breast Cancer Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa HER-2 Negative Breast Cancer by Region (2021-2026)
8.2 Middle East & Africa HER-2 Negative Breast Cancer Market Size by Type (2021-2026)
8.3 Middle East & Africa HER-2 Negative Breast Cancer Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL HER-2 NEGATIVE BREAST CANCER MARKET FORECAST

10.1 Global HER-2 Negative Breast Cancer Forecast by Region (2027-2032)
  10.1.1 Global HER-2 Negative Breast Cancer Forecast by Region (2027-2032)
  10.1.2 Americas HER-2 Negative Breast Cancer Forecast
  10.1.3 APAC HER-2 Negative Breast Cancer Forecast
  10.1.4 Europe HER-2 Negative Breast Cancer Forecast
  10.1.5 Middle East & Africa HER-2 Negative Breast Cancer Forecast
10.2 Americas HER-2 Negative Breast Cancer Forecast by Country (2027-2032)
  10.2.1 United States Market HER-2 Negative Breast Cancer Forecast
  10.2.2 Canada Market HER-2 Negative Breast Cancer Forecast
  10.2.3 Mexico Market HER-2 Negative Breast Cancer Forecast
  10.2.4 Brazil Market HER-2 Negative Breast Cancer Forecast
10.3 APAC HER-2 Negative Breast Cancer Forecast by Region (2027-2032)
  10.3.1 China HER-2 Negative Breast Cancer Market Forecast
  10.3.2 Japan Market HER-2 Negative Breast Cancer Forecast
  10.3.3 Korea Market HER-2 Negative Breast Cancer Forecast
  10.3.4 Southeast Asia Market HER-2 Negative Breast Cancer Forecast
  10.3.5 India Market HER-2 Negative Breast Cancer Forecast
  10.3.6 Australia Market HER-2 Negative Breast Cancer Forecast
10.4 Europe HER-2 Negative Breast Cancer Forecast by Country (2027-2032)
  10.4.1 Germany Market HER-2 Negative Breast Cancer Forecast
  10.4.2 France Market HER-2 Negative Breast Cancer Forecast
  10.4.3 UK Market HER-2 Negative Breast Cancer Forecast
  10.4.4 Italy Market HER-2 Negative Breast Cancer Forecast
  10.4.5 Russia Market HER-2 Negative Breast Cancer Forecast
10.5 Middle East & Africa HER-2 Negative Breast Cancer Forecast by Region (2027-2032)
  10.5.1 Egypt Market HER-2 Negative Breast Cancer Forecast
  10.5.2 South Africa Market HER-2 Negative Breast Cancer Forecast
  10.5.3 Israel Market HER-2 Negative Breast Cancer Forecast
  10.5.4 Turkey Market HER-2 Negative Breast Cancer Forecast
10.6 Global HER-2 Negative Breast Cancer Forecast by Type (2027-2032)
10.7 Global HER-2 Negative Breast Cancer Forecast by Application (2027-2032)
  10.7.1 GCC Countries Market HER-2 Negative Breast Cancer Forecast

11 KEY PLAYERS ANALYSIS

11.1 Eli Lilly and Company
  11.1.1 Eli Lilly and Company Company Information
  11.1.2 Eli Lilly and Company HER-2 Negative Breast Cancer Product Offered
  11.1.3 Eli Lilly and Company HER-2 Negative Breast Cancer Revenue, Gross Margin and Market Share (2021-2026)
  11.1.4 Eli Lilly and Company Main Business Overview
  11.1.5 Eli Lilly and Company Latest Developments
11.2 AstraZeneca
  11.2.1 AstraZeneca Company Information
  11.2.2 AstraZeneca HER-2 Negative Breast Cancer Product Offered
  11.2.3 AstraZeneca HER-2 Negative Breast Cancer Revenue, Gross Margin and Market Share (2021-2026)
  11.2.4 AstraZeneca Main Business Overview
  11.2.5 AstraZeneca Latest Developments
11.3 GSK
  11.3.1 GSK Company Information
  11.3.2 GSK HER-2 Negative Breast Cancer Product Offered
  11.3.3 GSK HER-2 Negative Breast Cancer Revenue, Gross Margin and Market Share (2021-2026)
  11.3.4 GSK Main Business Overview
  11.3.5 GSK Latest Developments
11.4 Novartis AG
  11.4.1 Novartis AG Company Information
  11.4.2 Novartis AG HER-2 Negative Breast Cancer Product Offered
  11.4.3 Novartis AG HER-2 Negative Breast Cancer Revenue, Gross Margin and Market Share (2021-2026)
  11.4.4 Novartis AG Main Business Overview
  11.4.5 Novartis AG Latest Developments
11.5 Pfizer
  11.5.1 Pfizer Company Information
  11.5.2 Pfizer HER-2 Negative Breast Cancer Product Offered
  11.5.3 Pfizer HER-2 Negative Breast Cancer Revenue, Gross Margin and Market Share (2021-2026)
  11.5.4 Pfizer Main Business Overview
  11.5.5 Pfizer Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. HER-2 Negative Breast Cancer Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. HER-2 Negative Breast Cancer Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Chemotherapy
Table 4. Major Players of Radiation
Table 5. Major Players of Hormonal Therapy
Table 6. Major Players of Others
Table 7. HER-2 Negative Breast Cancer Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global HER-2 Negative Breast Cancer Market Size by Type (2021-2026) & ($ millions)
Table 9. Global HER-2 Negative Breast Cancer Market Size Market Share by Type (2021-2026)
Table 10. HER-2 Negative Breast Cancer Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global HER-2 Negative Breast Cancer Market Size by Application (2021-2026) & ($ millions)
Table 12. Global HER-2 Negative Breast Cancer Market Size Market Share by Application (2021-2026)
Table 13. Global HER-2 Negative Breast Cancer Revenue by Player (2021-2026) & ($ millions)
Table 14. Global HER-2 Negative Breast Cancer Revenue Market Share by Player (2021-2026)
Table 15. HER-2 Negative Breast Cancer Key Players Head office and Products Offered
Table 16. HER-2 Negative Breast Cancer Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global HER-2 Negative Breast Cancer Market Size by Region (2021-2026) & ($ millions)
Table 20. Global HER-2 Negative Breast Cancer Market Size Market Share by Region (2021-2026)
Table 21. Global HER-2 Negative Breast Cancer Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global HER-2 Negative Breast Cancer Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas HER-2 Negative Breast Cancer Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas HER-2 Negative Breast Cancer Market Size Market Share by Country (2021-2026)
Table 25. Americas HER-2 Negative Breast Cancer Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas HER-2 Negative Breast Cancer Market Size Market Share by Type (2021-2026)
Table 27. Americas HER-2 Negative Breast Cancer Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas HER-2 Negative Breast Cancer Market Size Market Share by Application (2021-2026)
Table 29. APAC HER-2 Negative Breast Cancer Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC HER-2 Negative Breast Cancer Market Size Market Share by Region (2021-2026)
Table 31. APAC HER-2 Negative Breast Cancer Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC HER-2 Negative Breast Cancer Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe HER-2 Negative Breast Cancer Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe HER-2 Negative Breast Cancer Market Size Market Share by Country (2021-2026)
Table 35. Europe HER-2 Negative Breast Cancer Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe HER-2 Negative Breast Cancer Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa HER-2 Negative Breast Cancer Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa HER-2 Negative Breast Cancer Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa HER-2 Negative Breast Cancer Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of HER-2 Negative Breast Cancer
Table 41. Key Market Challenges & Risks of HER-2 Negative Breast Cancer
Table 42. Key Industry Trends of HER-2 Negative Breast Cancer
Table 43. Global HER-2 Negative Breast Cancer Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global HER-2 Negative Breast Cancer Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global HER-2 Negative Breast Cancer Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global HER-2 Negative Breast Cancer Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. Eli Lilly and Company Details, Company Type, HER-2 Negative Breast Cancer Area Served and Its Competitors
Table 48. Eli Lilly and Company HER-2 Negative Breast Cancer Product Offered
Table 49. Eli Lilly and Company HER-2 Negative Breast Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. Eli Lilly and Company Main Business
Table 51. Eli Lilly and Company Latest Developments
Table 52. AstraZeneca Details, Company Type, HER-2 Negative Breast Cancer Area Served and Its Competitors
Table 53. AstraZeneca HER-2 Negative Breast Cancer Product Offered
Table 54. AstraZeneca HER-2 Negative Breast Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. AstraZeneca Main Business
Table 56. AstraZeneca Latest Developments
Table 57. GSK Details, Company Type, HER-2 Negative Breast Cancer Area Served and Its Competitors
Table 58. GSK HER-2 Negative Breast Cancer Product Offered
Table 59. GSK HER-2 Negative Breast Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. GSK Main Business
Table 61. GSK Latest Developments
Table 62. Novartis AG Details, Company Type, HER-2 Negative Breast Cancer Area Served and Its Competitors
Table 63. Novartis AG HER-2 Negative Breast Cancer Product Offered
Table 64. Novartis AG HER-2 Negative Breast Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Novartis AG Main Business
Table 66. Novartis AG Latest Developments
Table 67. Pfizer Details, Company Type, HER-2 Negative Breast Cancer Area Served and Its Competitors
Table 68. Pfizer HER-2 Negative Breast Cancer Product Offered
Table 69. Pfizer HER-2 Negative Breast Cancer Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Pfizer Main Business
Table 71. Pfizer Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. HER-2 Negative Breast Cancer Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global HER-2 Negative Breast Cancer Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. HER-2 Negative Breast Cancer Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. HER-2 Negative Breast Cancer Sales Market Share by Country/Region (2025)
Figure 8. HER-2 Negative Breast Cancer Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global HER-2 Negative Breast Cancer Market Size Market Share by Type in 2025
Figure 10. HER-2 Negative Breast Cancer in Hospital
Figure 11. Global HER-2 Negative Breast Cancer Market: Hospital (2021-2026) & ($ millions)
Figure 12. HER-2 Negative Breast Cancer in Clinic
Figure 13. Global HER-2 Negative Breast Cancer Market: Clinic (2021-2026) & ($ millions)
Figure 14. HER-2 Negative Breast Cancer in Other
Figure 15. Global HER-2 Negative Breast Cancer Market: Other (2021-2026) & ($ millions)
Figure 16. Global HER-2 Negative Breast Cancer Market Size Market Share by Application in 2025
Figure 17. Global HER-2 Negative Breast Cancer Revenue Market Share by Player in 2025
Figure 18. Global HER-2 Negative Breast Cancer Market Size Market Share by Region (2021-2026)
Figure 19. Americas HER-2 Negative Breast Cancer Market Size 2021-2026 ($ millions)
Figure 20. APAC HER-2 Negative Breast Cancer Market Size 2021-2026 ($ millions)
Figure 21. Europe HER-2 Negative Breast Cancer Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa HER-2 Negative Breast Cancer Market Size 2021-2026 ($ millions)
Figure 23. Americas HER-2 Negative Breast Cancer Value Market Share by Country in 2025
Figure 24. United States HER-2 Negative Breast Cancer Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada HER-2 Negative Breast Cancer Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico HER-2 Negative Breast Cancer Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil HER-2 Negative Breast Cancer Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC HER-2 Negative Breast Cancer Market Size Market Share by Region in 2025
Figure 29. APAC HER-2 Negative Breast Cancer Market Size Market Share by Type (2021-2026)
Figure 30. APAC HER-2 Negative Breast Cancer Market Size Market Share by Application (2021-2026)
Figure 31. China HER-2 Negative Breast Cancer Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan HER-2 Negative Breast Cancer Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea HER-2 Negative Breast Cancer Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia HER-2 Negative Breast Cancer Market Size Growth 2021-2026 ($ millions)
Figure 35. India HER-2 Negative Breast Cancer Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia HER-2 Negative Breast Cancer Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe HER-2 Negative Breast Cancer Market Size Market Share by Country in 2025
Figure 38. Europe HER-2 Negative Breast Cancer Market Size Market Share by Type (2021-2026)
Figure 39. Europe HER-2 Negative Breast Cancer Market Size Market Share by Application (2021-2026)
Figure 40. Germany HER-2 Negative Breast Cancer Market Size Growth 2021-2026 ($ millions)
Figure 41. France HER-2 Negative Breast Cancer Market Size Growth 2021-2026 ($ millions)
Figure 42. UK HER-2 Negative Breast Cancer Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy HER-2 Negative Breast Cancer Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia HER-2 Negative Breast Cancer Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa HER-2 Negative Breast Cancer Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa HER-2 Negative Breast Cancer Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa HER-2 Negative Breast Cancer Market Size Market Share by Application (2021-2026)
Figure 48. Egypt HER-2 Negative Breast Cancer Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa HER-2 Negative Breast Cancer Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel HER-2 Negative Breast Cancer Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey HER-2 Negative Breast Cancer Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries HER-2 Negative Breast Cancer Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas HER-2 Negative Breast Cancer Market Size 2027-2032 ($ millions)
Figure 54. APAC HER-2 Negative Breast Cancer Market Size 2027-2032 ($ millions)
Figure 55. Europe HER-2 Negative Breast Cancer Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa HER-2 Negative Breast Cancer Market Size 2027-2032 ($ millions)
Figure 57. United States HER-2 Negative Breast Cancer Market Size 2027-2032 ($ millions)
Figure 58. Canada HER-2 Negative Breast Cancer Market Size 2027-2032 ($ millions)
Figure 59. Mexico HER-2 Negative Breast Cancer Market Size 2027-2032 ($ millions)
Figure 60. Brazil HER-2 Negative Breast Cancer Market Size 2027-2032 ($ millions)
Figure 61. China HER-2 Negative Breast Cancer Market Size 2027-2032 ($ millions)
Figure 62. Japan HER-2 Negative Breast Cancer Market Size 2027-2032 ($ millions)
Figure 63. Korea HER-2 Negative Breast Cancer Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia HER-2 Negative Breast Cancer Market Size 2027-2032 ($ millions)
Figure 65. India HER-2 Negative Breast Cancer Market Size 2027-2032 ($ millions)
Figure 66. Australia HER-2 Negative Breast Cancer Market Size 2027-2032 ($ millions)
Figure 67. Germany HER-2 Negative Breast Cancer Market Size 2027-2032 ($ millions)
Figure 68. France HER-2 Negative Breast Cancer Market Size 2027-2032 ($ millions)
Figure 69. UK HER-2 Negative Breast Cancer Market Size 2027-2032 ($ millions)
Figure 70. Italy HER-2 Negative Breast Cancer Market Size 2027-2032 ($ millions)
Figure 71. Russia HER-2 Negative Breast Cancer Market Size 2027-2032 ($ millions)
Figure 72. Egypt HER-2 Negative Breast Cancer Market Size 2027-2032 ($ millions)
Figure 73. South Africa HER-2 Negative Breast Cancer Market Size 2027-2032 ($ millions)
Figure 74. Israel HER-2 Negative Breast Cancer Market Size 2027-2032 ($ millions)
Figure 75. Turkey HER-2 Negative Breast Cancer Market Size 2027-2032 ($ millions)
Figure 76. Global HER-2 Negative Breast Cancer Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global HER-2 Negative Breast Cancer Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries HER-2 Negative Breast Cancer Market Size 2027-2032 ($ millions)